Fresenius SE Shares Outstanding 2016-2025 | FSNUY

Fresenius SE shares outstanding history from 2016 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Fresenius SE shares outstanding for the quarter ending December 31, 2025 were 2.253B, a 0% increase year-over-year.
  • Fresenius SE 2025 shares outstanding were 2.253B, a 0% decline from 2024.
  • Fresenius SE 2024 shares outstanding were 2.253B, a 0% decline from 2023.
  • Fresenius SE 2023 shares outstanding were 2.253B, a 0.35% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Fresenius SE Annual Shares Outstanding
(Millions of Shares)
2025 2,253
2024 2,253
2023 2,253
2022 2,245
2021 2,233
2020 2,231
2019 2,230
2018 2,229
2017 2,230
2016 2,200
2015 2,193
Fresenius SE Quarterly Shares Outstanding
(Millions of Shares)
2025-12-31 2,253
2025-09-30 2,253
2025-06-30 2,253
2025-03-31 2,253
2024-12-31 2,253
2024-09-30 2,248
2024-06-30 2,261
2024-03-31 2,253
2023-12-31 2,253
2023-09-30 2,253
2023-06-30 2,253
2023-03-31 2,253
2022-12-31 2,245
2022-09-30 2,253
2022-06-30 2,240
2022-03-31 2,234
2021-12-31 2,233
2021-09-30 2,232
2021-06-30 2,231
2021-03-31 2,231
2020-12-31 2,231
2020-09-30 2,218
2020-06-30 2,222
2020-03-31 2,231
2019-12-31 2,230
2019-09-30 2,248
2019-06-30 2,216
2019-03-31 2,229
2018-12-31 2,229
2018-09-30 2,235
2018-06-30 2,222
2018-03-31 2,230
2017-12-31 2,230
2017-09-30 2,231
2017-06-30 2,222
2017-03-31 2,231
2016-12-31 2,200
2016-09-30 2,200
2016-06-30 2,200
2016-03-31 2,200
2015-12-31 2,182
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $29.514B $25.873B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
U.S Physical Therapy (USPH) United States $1.157B 29.19
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00